Subcutaneous Testosterone Is Effective and Safe as Gender-Affirming Hormone Therapy in Transmasculine and Gender-Diverse Adolescents and Young Adults: A Single Center's 8-Year Experience.

Transgend Health · 2021 · PMC8664110 · PMID 34988290

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

Although increases in AST and ALT from baseline to final follow-up were statistically significant and borderline significant, respectively, those were not clinically significant and follow-up values for both parameters remained normal.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.